
Podcast #35 · 14 Nov 2025
NSCLC Tumor Board Discussion: Considerations for Oligometastatic Disease
- Radiation Oncology
- Multidisciplinary Care
- Medical Oncology
- Chemotherapy
- Immunotherapy
- Non-Small Cell Lung Cancer (NSCLC)
- Oligometastatic Disease
- Thoracic Oncology
- 2025 NSCLC Creator Weekend™
- Brain Metastasis
- Radiology
- Tumor Board
- Resection
- Surgical Oncology
When cancer spreads to the brain, what is the best approach: immediate local treatment or systemic immunotherapy first? Part two of the 2025 NSCLC Creator Weekend™ series focuses on a complex case involving a 75-year-old woman with a history of breast malignancy, presenting with new dyspnea and a large mass in the left lower lobe.
This podcast is supported by an educational grant from Johnson & Johnson and Varian.
Timestamps
Resources
More about this episode
Our mock tumor board consists of surgeons, medical oncologists, and radiation oncologists to deliberate and determine the best treatment plan. The specialists explore diagnostic and treatment options, including neoadjuvant chemoimmunotherapy, invasive mediastinal staging, and the potential for surgical resection or radiation therapy.

